BETA-LACTAMASE INHIBITOR
SULBOFORTE-2GM
Sulbactam for Injection 2.0 gm
SULBOFORTE-2GM provides targeted high-dose sulbactam therapy which irreversibly binds and inactivates beta-lactamases, demonstrating intrinsic activity against Acinetobacter baumannii.
Clinical Indications
- Multidrug-resistant Acinetobacter baumannii infections
- Severe hospital-acquired and ventilator-associated pneumonia
- Synergistic resistance-breaking combination therapy
- Complicated intra-abdominal and soft tissue infections